Our experimental investigations demonstrated that FGF21 reversed hyperglycemia-induced suppression of physiological retinal vascularization (Phase I retinopathy) by increasing circulating APN and modulating fatty acid oxidation (Fig. 7). Here, ANPEP is linked to retinal disorder.